Ashish Mahendra

Dr. Ashish Mahendra


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2017 in The Surgeon
Verified
Journal Article
Closed access
DSDavid W. Shields
David W. Shields
SSSadaf Sohrabi
Sadaf Sohrabi
ECEvan O. Crane
Evan O. Crane
CNChris Nicholas
Chris Nicholas
AMAshish Mahendra
Ashish Mahendra

6 July 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
OGOfir Ben Gal
Ofir Ben Gal
TSTerrence Chi Fang Soh
Terrence Chi Fang Soh
SVSarah Vaughan
Sarah Vaughan
VJViswanath Jayasanker
Viswanath Jayasanker
AMAshish Mahendra
Ashish Mahendra
SGSanjay Gupta
Sanjay Gupta
Individualized survival prognostic models for symptomatic patients with appendicular metastatic bone disease are key to guiding clinical decision-making for the orthopedic surgeon. Several prognostic models have been developed in recent years; however, most orthopedic surgeons have not incorporated these models into routine practice. This is possibly due to uncertainty concerning their accuracy and the lack of comparison publications and recommendations. Our aim was to conduct a review and quality assessment of these models. A computerized literature search in MEDLINE, EMBASE and PubMed up to February 2022 was done, using keywords: “Bone metastasis”, “survival”, “extremity” and “prognosis”. We evaluated each model’s performance, assessing the estimated discriminative power and calibration accuracy for the analyzed patients. We included 11 studies out of the 1779 citations initially retrieved. The 11 studies included seven different models for estimating survival. Among externally validated survival prediction scores, PATHFx 3.0, 2013-SPRING and potentially Optimodel were found to be the best models in terms of performance. Currently, it is still a challenge to recommend any of the models as the standard for predicting survival for these patients. However, some models show better performance status and other quality characteristics. We recommend future, large, multicenter, prospective studies to compare between PATHfx 3.0, SPRING 2013 and OptiModel using the same external validation dataset.

1 April 2016 in The Surgeon
Verified
Journal Article
Closed access
KFKim B. Ferguson
Kim B. Ferguson
JMJennifer McGlynn
Jennifer McGlynn
MJMichael Jane
Michael Jane
DRDavid Ritchie
David Ritchie
AMAshish Mahendra
Ashish Mahendra

1 December 2021 in Bone & Joint Open
Verified
Journal Article
Open access
DSDavid W. Shields
David W. Shields
NRNima Razii
Nima Razii
JDJames Doonan
James Doonan
AMAshish Mahendra
Ashish Mahendra
SGSanjay Gupta
Sanjay Gupta
Aims The primary objective of this study was to compare the postoperative infection rate between negative pressure wound therapy (NPWT) and conventional dressings for closed incisions following soft-tissue sarcoma (STS) surgery. Secondary objectives were to compare rates of adverse wound events and functional scores. Methods In this prospective, single-centre, randomized controlled trial (RCT), patients were randomized to either NPWT or conventional sterile occlusive dressings. A total of 17 patients, with a mean age of 54 years (21 to 81), were successfully recruited and none were lost to follow-up. Wound reviews were undertaken to identify any surgical site infection (SSI) or adverse wound events within 30 days. The Toronto Extremity Salvage Score (TESS) and Musculoskeletal Tumor Society (MSTS) score were recorded as patient-reported outcome measures (PROMs). Results There were two out of seven patients in the control group (28.6%), and two out of ten patients in the intervention group (20%) who were diagnosed with a SSI (p > 0.999), while one additional adverse wound event was identified in the control group (p = 0.593). No significant differences in PROMs were identified between the groups at either 30 days (TESS, p = 0.987; MSTS, p = 0.951) or six-month (TESS, p = 0.400) follow-up. However, neoadjuvant radiotherapy was significantly associated with a SSI within 30 days of surgery, across all patients (p = 0.029). The mean preoperative modified Glasgow Prognostic Score (mGPS) was also significantly higher among patients who developed a postoperative adverse wound event (p = 0.028), including a SSI (p = 0.008), across both groups. Conclusion This is the first RCT comparing NPWT with conventional dressings following musculoskeletal tumour surgery. Postoperative wound complications are common in this group of patients and we observed an overall SSI rate of 23.5%. We propose proceeding to a multicentre trial, which will help more clearly define the role of closed incision NPWT in STS surgery. Cite this article: Bone Jt Open 2021;2(12):1049–1056.

20 July 2016 in Journal of Hand Surgery (European Volume)
Verified
Journal Article
Closed access
KFK. B. Ferguson
K. B. Ferguson
MJM. Jane
M. Jane
AMAshish Mahendra
Ashish Mahendra

3 December 2014 in The Foot
Verified
Journal Article
Closed access
PYP.S. Young
P.S. Young
VCV.L. Clement
V.L. Clement
ALA. Lomax
A. Lomax
JBJ. Badhesha
J. Badhesha
RMR.J. Miller
R.J. Miller
AMAshish Mahendra
Ashish Mahendra